Market Tracker

08/20 2:29pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

9.30
Data as of 2:14pm ET
 +0.46 / +5.20%
Today’s Change
7.44
Today|||52-Week Range
82.80
-16.22%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close8.84
Today’s open8.81
Day’s range8.65 - 9.50
Volume14,858
Average volume (3 months)59,227
Market cap$114.3M
Dividend yield--
Data as of 2:14pm ET, 08/20/2014

Growth & Valuation

Earnings growth (last year)+26.32%
Earnings growth (this year)+88.39%
Earnings growth (next 5 years)--
Revenue growth (last year)+17.38%
P/E ratio2.9
Price/Sales1.73
Price/Book1.63

Competitors

 Today’s
change
Today’s
% change
OCRXOcera Therapeutics I...+0.02+0.35%
CRMECardiome Pharma Corp-0.02-0.28%
ATHXAthersys Inc0.000.00%
VICLVical Inc+0.01+0.79%
Data as of 2:14pm ET, 08/20/2014

Financials

Last reporting dateAugust 6, 2014
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$14.7M
Annual profit (last year)-$38.6M
Net profit margin-262.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts